Broadly neutralizing antibodies abrogate established hepatitis C virus infection - Wikidata - awgldk - TriplyDB

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

http://www.wikidata.org/entity/Q35032263

about

Recent advances in understanding hepatitis C Immune and non-immune responses to hepatitis C virus infection Animal models for the study of HCV Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?Engineering humoral immunity as prophylaxis or therapy Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus Innate and Adaptive Immune Regulation During Chronic Viral Infections Proteomic approaches to analyzing hepatitis C virus biology Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design Gain-of-Function Research and the Relevance to Clinical Practice.The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1 Broadly reactive aptamers targeting bacteria belonging to different genera using a sequential toggle cell-SELEX Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection New perspectives for preventing hepatitis C virus liver graft infection.In vivo models of hepatitis B and C virus infection.Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.Humanized Mouse Models of Clinical Disease.State of play and clinical prospects of antibody gene transfer.Hepatitis B virus receptors and molecular drug targets.A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.Viral evasion and challenges of hepatitis C virus vaccine development.Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection Humanized mice: A brief overview on their diverse applications in biomedical research.

P2860

Q26766136-48470581-7586-4F05-8F40-2F38903E8895 Q26782040-0CF36C58-5110-4818-A81D-E1E9E741C75F Q26797836-F5769263-8AB9-4F6B-9B4D-BDA69D006077 Q26799141-F69F41B0-9932-4368-8708-F0A6B25D211F Q26800101-92F11E9D-2991-4D1D-AEF5-822EFEC01988 Q26801759-8DEEAA29-5E90-436C-870D-C3AE2826CCFD Q27468870-47722ACA-539D-41DC-A9C0-F253116B94DF Q27469019-41720838-6258-4C10-A7BB-99CD11D00CF6 Q28079717-C2F9B1C5-FAFC-408D-B081-E957255F738E Q28085146-71A091D4-AAE4-4835-81D7-96A96B76CFC0 Q28552909-9E356E42-5071-4D51-8E8A-248EA3E6D8DD Q30374314-32177895-41E8-46AA-8895-4BE5711510AF Q30379683-082140D2-6818-4BF8-9841-F11B8A99EA34 Q33612608-00690ED9-295E-472C-917E-E06836A3AF78 Q33631104-19A6E137-4DAB-4808-9C15-F86CE02F34C8 Q33899640-530764B0-D452-4C92-8919-783380CC76F8 Q34495762-CFDD31FB-CC4D-4B89-8A54-3DC4E3A6CE1B Q35788314-1FCC7962-21B5-41F5-99C2-024A744A0D06 Q35993488-0BFA0B80-D408-45BD-946C-E6002A6FF0F2 Q36064836-74F41F7A-F9CE-4390-A74D-BDBD422647DE Q36281615-9F77C8C4-DCE3-4A4D-A094-C63488BC7EC3 Q36288404-22E1FD97-F9BE-4B2D-9253-321E998B466B Q36290295-662D537B-6EE3-4914-833C-0036D23DA961 Q36300521-845B9F02-F205-4694-B1F6-12A509665A52 Q36584038-F9EB3264-4710-4621-AE32-48F292D53214 Q36811958-5108B597-C08B-4069-AD13-BD5221EF6A99 Q37015805-8FFCFCBF-C20A-44A0-AB52-D5BB3B3AA819 Q37095706-6E40FF0A-50D0-4D8B-9B53-82E1AE7AA349 Q37252935-E2A9535C-6882-47C9-B122-940437252849 Q37415463-5454F73D-5C71-4FAC-BD9F-8905ABB1EB7C Q37614202-F75266D9-AB26-42F1-AF46-13B7ED78CEB6 Q38737706-E60A2291-5580-42D4-BE4C-21EE8FE527BB Q38775846-66513ECB-3AD0-4279-9F64-2EF2C950AC7E Q38843133-D2EF806E-3239-49F1-9958-5998144ABDA5 Q38945754-196F1ADB-0B29-49AB-868C-A4874FE749E9 Q38961608-C04227C9-6BB9-41AB-8413-5C68990B5887 Q38997064-59A66656-B183-4A17-9348-E2A8F963D79F Q39285745-086D4604-646A-485A-A400-8620044597D0 Q39327457-6787EFE6-46EF-4F8B-81D1-5B0999A676C2 Q39329450-DCE8A112-57AD-45F7-A5EC-90747663DF85

P2860

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

http://www.wikidata.org/entity/Q35032263

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@ast

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@en

type

label

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@ast

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@en

prefLabel

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@ast

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@en

P1433

Q35032263-DDFC3394-AD7B-49DE-96F4-080D1FA454EE

P1476

Q35032263-75520486-AF4F-4F0D-8619-C4E6DAC27C9D

P2093

Q35032263-13063423-CCF3-4376-AD34-C22A8E0703DE

Q35032263-2571E0BD-4833-4065-A69A-13DFCBF3104C

Q35032263-2C114D28-CECD-4867-A230-85949D601E7F

Q35032263-376B2FBA-A108-4E44-A07D-1973DB0DF49E

Q35032263-3F2589AE-6EE9-40F9-A686-5357C56D4E8E

Q35032263-492143CB-515A-48DD-9029-B288F07BFB51

Q35032263-5992410B-78A9-4A5E-B8F4-6382F46C2BA0

Q35032263-61813BDB-294E-4187-8D2A-3EC4C7B327F3

Q35032263-8B88D9B3-A503-4B66-96CA-3AFFF874BFC0

Q35032263-93A87249-8454-40DE-90C8-07B4E22766A2

P2860

Q35032263-01D81C18-679E-4CFA-A446-67B166546D05

Q35032263-02CC82A9-58DA-426D-8A3B-F0642A4A9A84

Q35032263-06B2D7EE-FE46-4BA4-8F06-A3BA88D2571A

Q35032263-099341D3-4C8B-4D1D-AF9C-796DBA0634BC

Q35032263-0B028318-EF8B-45B8-9054-B87C387FC3F3

Q35032263-125364C2-D01B-4883-9607-F9DDEA273AAF

Q35032263-158DA087-419F-4270-81CE-55468EB0C334

Q35032263-1AFE1598-726F-43D8-A4D8-A2C946911D6D

Q35032263-2533A54E-0CCA-4A04-A7C2-6893B5BA847F

Q35032263-28A8B942-7D3B-49AB-A3C0-D9EE84330C3C

P304

Q35032263-FA2A26C0-B071-4572-A98C-DA99C74DE3DA

P31

Q35032263-F0E353BD-F140-49C2-A19A-7A819C830AC3

P356

Q35032263-37EEC996-7DE7-4B10-8D6F-0F55B2DE7313

P407

Q35032263-2A10E706-6D4F-4837-A2BD-932AD10BD329

P433

Q35032263-4D3BD9B4-DAB7-4201-8931-5FD2606F62D8

P478

Q35032263-7B5F0E0C-F16B-48C6-A89A-BD6CEA1A1576

P50

Q35032263-1778E3DC-559D-4DF8-8FB7-899EA7296090

Q35032263-437CEE01-AD78-4B82-B067-DE42F733B2D8

Q35032263-91184C65-F32F-4CBB-9CC9-6E33CCF8D1E7

Q35032263-F6365992-0B01-47ED-87B9-8F9F5E91D8AA

P577

Q35032263-6510E964-942C-4DC7-A29E-AA8A57469AC3

P5875

Q35032263-282AB134-98DB-4798-AD9F-DAF641E6E9C0

P698

Q35032263-9FCFDB38-7C44-4E2D-9F9B-CDF47E37F253

P921

Q35032263-E30BD270-FF56-4D7E-95B1-30EB77E9445F

P932

Q35032263-6EF50295-708C-4372-871F-12F18BF00C8F

P356

SCITRANSLMED.3009512

P1433

Science Translational Medicine

P1476

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

@en

P2093

Alejandro B Balazs

http://www.w3.org/2001/XMLSchema#string

Alexander Ploss

http://www.w3.org/2001/XMLSchema#string

Anuradha Krishnan

http://www.w3.org/2001/XMLSchema#string

Bridget M Donovan

http://www.w3.org/2001/XMLSchema#string

Charles M Rice

http://www.w3.org/2001/XMLSchema#string

David Baltimore

http://www.w3.org/2001/XMLSchema#string

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Erick Giang

http://www.w3.org/2001/XMLSchema#string

Jing W Xiao

http://www.w3.org/2001/XMLSchema#string

Justin B Robbins

http://www.w3.org/2001/XMLSchema#string

P2860

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

Complete replication of hepatitis C virus in cell culture

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees

P304

254ra129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3009512

http://www.w3.org/2001/XMLSchema#string

P407

P433

254

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin Y Winer

Michiel C Mommersteeg

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267756541

http://www.w3.org/2001/XMLSchema#string

P698

25232181

http://www.w3.org/2001/XMLSchema#string

P921

P932

4312107

http://www.w3.org/2001/XMLSchema#string